Flurithromycin ethylsuccinate

氟红霉素琥珀酸乙酯

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameFlurithromycin ethylsuccinate
Drug Alias NameflurithromycinumfluritromicinaflurithromycineFlurizicMizar +[9
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPierrel Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOspedale Monaldi Di Napoli
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeJ01FA14
Related LinksN/A